Search scope:
排序: Display mode:
Molecular markers and pathogenically targeted therapy in non-small cell lung cancer
Bo PENG BA , Jinnong ZHANG MD , Jamile S. WOODS MD , Wei PENG MD, PhD
Frontiers of Medicine 2009, Volume 3, Issue 3, Pages 245-255 doi: 10.1007/s11684-009-0044-3
Keywords: lung cancer carcinoma non-small cell lung cancer molecular markers targeted therapy
Molecular classification and molecular targeted therapy of cancer
Miao Xu, Jianyong Shao, Yixin Zeng
Frontiers of Medicine 2013, Volume 7, Issue 2, Pages 147-149 doi: 10.1007/s11684-013-0274-2
mTOR-targeted cancer therapy: great target but disappointing clinical outcomes, why?
Shi-Yong Sun
Frontiers of Medicine 2021, Volume 15, Issue 2, Pages 221-231 doi: 10.1007/s11684-020-0812-7
Keywords: mTOR cancer therapy resistance GSK3 protein degradation E3 ubiquitin ligase PD-L1
Targeted therapy of desmoid-type fibromatosis: mechanism, current situation, and future prospects
Zhen Wang, Jianhui Wu, Xiuyun Tian, Chunyi Hao
Frontiers of Medicine 2019, Volume 13, Issue 4, Pages 427-437 doi: 10.1007/s11684-018-0672-6
Keywords: targeted therapy desmoid-type fibromatosis tyrosine kinase inhibitor γ-secretase inhibitor
Frontiers of Medicine 2024, Volume 18, Issue 3, Pages 570-570 doi: 10.1007/s11684-024-1076-4
Keywords: therapy NSCLC unreliability variant allele
Progress and challenges in RET-targeted cancer therapy
Frontiers of Medicine 2023, Volume 17, Issue 2, Pages 207-219 doi: 10.1007/s11684-023-0985-y
Keywords: pralsetinib selpercatinib RET-alteration lung cancer thyroid cancer tumor-agnostic therapy drug
Liangqian Tong, Ming Zhao, Shu Zhu, Jing Chen
Frontiers of Medicine 2011, Volume 5, Issue 4, Pages 379-387 doi: 10.1007/s11684-011-0162-6
Keywords: nanoparticles superparamagnetic iron oxide targeted therapy molecular imaging cancer
Frontiers of Medicine 2023, Volume 17, Issue 3, Pages 493-502 doi: 10.1007/s11684-022-0946-x
Keywords: situ hybridization immunohistochemistry variant allele frequency intratumoral heterogeneity targetedtherapy
Pengming SUN PhD, MD , Jalid SEHOULI PhD, MD , Lihui WEI BM ,
Frontiers of Medicine 2009, Volume 3, Issue 3, Pages 256-264 doi: 10.1007/s11684-009-0052-3
Keywords: target therapy gynecologic malignant tumors clinical trail molecular medicine
Precision medicine in acute lymphoblastic leukemia
Ching-Hon Pui
Frontiers of Medicine 2020, Volume 14, Issue 6, Pages 689-700 doi: 10.1007/s11684-020-0759-8
Keywords: acute lymphoblastic leukemia molecular therapeutics targeted therapy tyrosine kinase inhibitors immunotherapy CAR T-cell therapy
Progress in systemic therapy for triple-negative breast cancer
Hongnan Mo, Binghe Xu
Frontiers of Medicine 2021, Volume 15, Issue 1, Pages 1-10 doi: 10.1007/s11684-020-0741-5
Keywords: triple-negative breast cancer immunotherapy targeted therapy
Influence of Survivin-targeted siRNA on the biological features of colorectal carcinoma cells
XIONG Ying, GUO Wen, LI Ting, LI Ke
Frontiers of Medicine 2007, Volume 1, Issue 3, Pages 304-307 doi: 10.1007/s11684-007-0058-7
Keywords: control therapy influence Survivin-1 colorectal carcinoma
Yinlong Zhang, Guangna Liu, Jingyan Wei, Guangjun Nie
Frontiers of Medicine 2018, Volume 12, Issue 6, Pages 667-677 doi: 10.1007/s11684-017-0583-y
Keywords: platelet-mimicking delivery systems tumor-associated platelets cancer therapy EPR effect
Wenjie Zhu, Binghe Xu
Frontiers of Medicine 2021, Volume 15, Issue 2, Pages 208-220 doi: 10.1007/s11684-020-0795-4
Keywords: endocrine-resistant HR+/HER2- advanced breast cancer randomized clinical trials meta-analysis targetedtherapy
Taking advantage of drug resistance, a new approach in the war on cancer
Liqin Wang, Rene Bernards
Frontiers of Medicine 2018, Volume 12, Issue 4, Pages 490-495 doi: 10.1007/s11684-018-0647-7
Keywords: cancer drug resistance genetic screens senescence targeted therapy
Title Author Date Type Operation
Molecular markers and pathogenically targeted therapy in non-small cell lung cancer
Bo PENG BA , Jinnong ZHANG MD , Jamile S. WOODS MD , Wei PENG MD, PhD
Journal Article
Molecular classification and molecular targeted therapy of cancer
Miao Xu, Jianyong Shao, Yixin Zeng
Journal Article
mTOR-targeted cancer therapy: great target but disappointing clinical outcomes, why?
Shi-Yong Sun
Journal Article
Targeted therapy of desmoid-type fibromatosis: mechanism, current situation, and future prospects
Zhen Wang, Jianhui Wu, Xiuyun Tian, Chunyi Hao
Journal Article
Erratum to: Potential unreliability of variant allele frequency in the efficacy prediction of targetedtherapy in NSCLC
Journal Article
Synthesis and application of superparamagnetic iron oxide nanoparticles in targeted therapy and imaging
Liangqian Tong, Ming Zhao, Shu Zhu, Jing Chen
Journal Article
Potential unreliability of ALK variant allele frequency in the efficacy prediction of targeted therapy
Journal Article
Molecular targeted therapy of gynecological malignant tumors: the development and challenge, from laboratory
Pengming SUN PhD, MD , Jalid SEHOULI PhD, MD , Lihui WEI BM ,
Journal Article
Progress in systemic therapy for triple-negative breast cancer
Hongnan Mo, Binghe Xu
Journal Article
Influence of Survivin-targeted siRNA on the biological features of colorectal carcinoma cells
XIONG Ying, GUO Wen, LI Ting, LI Ke
Journal Article
Platelet membrane-based and tumor-associated platelet- targeted drug delivery systems for cancer therapy
Yinlong Zhang, Guangna Liu, Jingyan Wei, Guangjun Nie
Journal Article
Overcoming resistance to endocrine therapy in hormone receptor-positive human epidermal growth factor
Wenjie Zhu, Binghe Xu
Journal Article